Management of hepatitis C virus genotype 4: recommendations of an international expert panel
Authors
Mahmoud A Khattab, Peter Ferenci, Stephanos J Hadziyannis, Massimo Colombo, Michael P Manns, Piero L Almasio, Rafael Esteban, Ayman A Abdo, Stephen A Harrison, Nazir Ibrahim, Patrice Cacoub, Mohammed Eslam, Samuel S Lee
Publication date
2011/6/1
Source
Journal of hepatology
Volume
54
Issue
6
Pages
1250-1262
Publisher
Elsevier
Description
HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in the world, it has not been the subject of widespread research. Therefore, this document, drafted by a panel of international experts, aimed to review current knowledge on the epidemiology, natural history, clinical …
Total citations
20112012201320142015201620172018
Scholar articles
Attachement Files


Syrian Private University - Members @ 2024 by Syrian Monster - Web Service Provider | All Rights Reserved